The Globe and Mail reports in its Tuesday edition that Haywood Securities analyst Colin Healey says Azarga Uranium (26 cents) is "poised for success" in the United States. The Globe's David Leeder writes that Mr. Healey commenced coverage of the Colorado-based company with a "buy" rating. Mr. Healey set a share target of 50 cents. Mr. Healey calls Azarga's Dewey Burdock in-situ recovery uranium project in South Dakota "among the highest grade undeveloped ISR uranium project in the U.S., and well above some existing producers" and believes it is "poised to deliver stock-catalyzing news flow in 2019." He says in a note: "The U.S. Department of Commerce has carried out an investigation of the domestic uranium supply chain as it pertains to national security under Section 232 of the U.S. Trade Expansion Act of 1962. The results and recommendations of that investigation were delivered to the White House in April of 2019. The President now has until mid-July 2019 to make a decision based on those recommendations and we believe this is likely to result in some type of incentive for domestic uranium suppliers in the form of tariffs or import quotas, which will lead to higher realized prices for uranium in the U.S."
© 2019 Canjex Publishing Ltd. All rights reserved.